[Weekly IPO Trends] 3 Companies Including Jincostech File for Listing... Lemon Healthcare Listed

In the IPO market during the second week of July 2026 (July 6-10), there were 3 listing review applications, 1 public offering process (demand forecasting), 1 payment, and 1 approved listing.

Listing Applications

• Jincostech: Filed for a preliminary examination on July 6 for a listing on the KOSDAQ market. It is a beauty company that specializes in manufacturing and producing (ODM/OEM) highly functional cosmetic patches and mask packs based on its proprietary hydrogel and biocellulose technologies. The lead underwriter is Hana Securities Co., Ltd.

• Nanosolution: Filed for a preliminary examination on July 6 for a listing on the KONEX market. It is a company that develops conductive plastic materials and highly functional nano-composite materials for anti-static and electromagnetic wave shielding based on carbon nanotube (CNT) processing technology. The lead underwriter is Korea Investment & Securities Co., Ltd.

• CIS Chemical: Filed for a preliminary examination on July 9 for a listing on the KOSDAQ market. It is a secondary battery materials company specializing in refining and producing high-purity alumina, precursor materials, and recycled raw materials, which are core materials for cathode materials used in lithium secondary batteries. The lead underwriter is KB Securities Co., Ltd.

Demand Forecasting

• Ingenia Therapeutics: A Korean-American bio company developing new drugs for intractable vascular diseases, such as diabetic macular edema and wet macular degeneration, based on a protein engineering technology platform (Tie2 activation). It conducted demand forecasting targeting institutional investors with Samsung Securities as the lead underwriter.

Payment

• Remedi: Completed the public offering payment procedure for its listing on the KOSDAQ market. The lead underwriter is KB Securities Co., Ltd.

Listing

• Lemon Healthcare: Newly listed on the KOSDAQ market with KB Securities Co., Ltd. as the lead underwriter. It is a patient-centric, one-stop digital healthcare platform company that handles hospital appointments, medical bill payments, and indemnity insurance claims all at once via a smartphone.

Next Week's Schedule

• HL Genomics: Public offering subscription and payment for its KOSDAQ listing are scheduled to take place next week. It is a genome analysis specialized company providing early diagnosis of cancer and rare diseases, as well as customized healthcare solutions utilizing next-generation sequencing (NGS)-based genetic testing technologies. The lead underwriters are KB Securities and IBK Investment & Securities.

• Remedi: Scheduled to be newly listed on the KOSDAQ market next week. It is a specialized company developing portable medical and dental X-ray devices as well as radiation devices for cancer treatment based on highly focused X-ray generation technology. The lead underwriter is KB Securities Co., Ltd.